Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064
I‐Ming Chen(Nanyang Technological University), Susan H. Eshleman(Johns Hopkins University), James P. Hughes(University of Washington), Sally Hodder(West Virginia University), Autumn Breaud(Johns Hopkins University), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jonathan Lucas(Family Health International 360), Paul Richardson(University of Liverpool), Jessica Justman(Columbia University Irving Medical Center), Danielle F. Haley(Emory University), Mark A. Marzinke(Family Health International 360), Jing Wang(King University), William Clarke(Johns Hopkins University), San-San Ou(Fred Hutch Cancer Center), Anne Rompalo(Johns Hopkins University)
Cited by 13
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
|Neurology|1989|4.1k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891